4-cyano-N-((S)-1-(4-((1S,2S)-2-(pyridin-3-yl)cyclopropane-1-carboxamido)phenyl)ethyl)benzamide

ID: ALA4211212

PubChem CID: 145964787

Max Phase: Preclinical

Molecular Formula: C25H22N4O2

Molecular Weight: 410.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)c1ccc(C#N)cc1)c1ccc(NC(=O)[C@H]2C[C@@H]2c2cccnc2)cc1

Standard InChI:  InChI=1S/C25H22N4O2/c1-16(28-24(30)19-6-4-17(14-26)5-7-19)18-8-10-21(11-9-18)29-25(31)23-13-22(23)20-3-2-12-27-15-20/h2-12,15-16,22-23H,13H2,1H3,(H,28,30)(H,29,31)/t16-,22+,23-/m0/s1

Standard InChI Key:  GQINRUWVBHJYMR-FNVCAUGXSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   24.9064  -15.4853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9053  -16.3090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6174  -16.7180    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3312  -16.3085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3284  -15.4817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6156  -15.0723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4623  -15.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1757  -15.4711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4593  -14.2397    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8860  -15.0557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5913  -15.4675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3011  -15.0528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2984  -14.2306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5801  -13.8248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8773  -14.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0082  -13.8184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7221  -14.2234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0377  -15.0678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7521  -15.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7487  -14.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7474  -16.2902    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   27.0333  -14.2472    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   33.4267  -13.8094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1375  -14.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4205  -12.9922    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.0040  -13.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1397  -15.0283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8497  -15.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5553  -15.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5464  -14.1961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8359  -13.7966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2662  -15.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9775  -15.8213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5 18  1  0
 19  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 19 18  1  0
 19 20  1  0
 18 20  1  0
 19 21  1  1
 18 22  1  6
 17 23  1  0
 23 24  1  0
 23 25  2  0
 16 26  1  6
 24 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 24  1  0
 32 33  3  0
 29 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4211212

    ---

Associated Targets(Human)

A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COR-L23 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 410.48Molecular Weight (Monoisotopic): 410.1743AlogP: 4.19#Rotatable Bonds: 6
Polar Surface Area: 94.88Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.89CX Basic pKa: 4.90CX LogP: 3.27CX LogD: 3.26
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.64Np Likeness Score: -1.58

References

1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA..  (2018)  Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen.,  28  (3): [PMID:29275937] [10.1016/j.bmcl.2017.12.037]

Source